You just read:

Biohaven Announces Positive Results From Bioequivalence Study With Sublingual BHV-0223 Zydis® Orally Dissolving Tablet

News provided by

Biohaven Pharmaceuticals, Inc.

Jan 09, 2018, 03:00 ET